India is in a better condition due to the cost advantage we have in using digital technology and software. The drug discovery and development process ...
Read more: Vaccine development is a very complex process; developing a vaccine in a year's time is a very ...
Sunday, May 31, 2020
Pharma Reviews: India will serve as the pharmacy of the world: Ashwini Kumar Choubey
Highlighting India's rich history in pharma, he urged the sector to foster innovation, acknowledging the significance of a platform like Corpgini that has ...
Read more: India will serve as the pharmacy of the world: Ashwini Kumar Choubey
Read more: India will serve as the pharmacy of the world: Ashwini Kumar Choubey
Pharma Reviews: Morning News
14 special flight to bring home more than 2000 Indian nationals from Gulf countries ... Interacting with the leaders in the Pharmaceutical industry and ...
Read more: Morning News
Read more: Morning News
Pharma Reviews: SGX Nifty jumps 170 points; here's what changed for market while you were sleeping
But the spike in Covid 19 cases in India, US-China tensions over Hong ... During his interaction with the captains of the pharmaceutical industry, and ...
Read more: SGX Nifty jumps 170 points; here's what changed for market while you were sleeping
Read more: SGX Nifty jumps 170 points; here's what changed for market while you were sleeping
Pharma Reviews: Cos await pick-up in demand to boost mfg
Another challenge that remains is the supply from the packaging and ancillary industry, said Sudarshan Jain, secretary general of Indian Pharmaceutical ...
Read more: Cos await pick-up in demand to boost mfg
Read more: Cos await pick-up in demand to boost mfg
Pharma Reviews: Two Pakistani High Commission officials caught spying, used to meet defence personnel
Both have been declared persona non grata and expelled from India. ... During an interaction with industry leaders of the pharmaceutical sector, ...
Read more: Two Pakistani High Commission officials caught spying, used to meet defence personnel
Read more: Two Pakistani High Commission officials caught spying, used to meet defence personnel
Pharma Reviews: Centre to sell stake in certain pharma PSUs: Goyal
During an interaction with industry leaders of the pharmaceutical sector, he invited the Indian companies to use PSUs for 'plug and play' model of ...
Read more: Centre to sell stake in certain pharma PSUs: Goyal
Read more: Centre to sell stake in certain pharma PSUs: Goyal
Pharma Reviews: Covid-19 Bulletin: Top Corona News of the Day, Do's and Don'ts of fighting the pandemic
Union Minister today lauded the pharmaceutical industry for standing up to challenge in such troubling times and said that India is emerging as the ...
Read more: Covid-19 Bulletin: Top Corona News of the Day, Do's and Don'ts of fighting the pandemic
Read more: Covid-19 Bulletin: Top Corona News of the Day, Do's and Don'ts of fighting the pandemic
Pharma Reviews: India recognized as 'world's pharmacy' amid Covid, says Goyal; urges firms to explore these markets
Pharmaceuticals is among the 10 sectors in government's focus to attract companies looking to move out of China. The government is developing a land ...
Read more: India recognized as 'world's pharmacy' amid Covid, says Goyal; urges firms to explore these markets
Read more: India recognized as 'world's pharmacy' amid Covid, says Goyal; urges firms to explore these markets
Saturday, May 30, 2020
Pharma Reviews: US pharma giant seeks marketing authorisation from India for remdesivir
A US pharmaceutical giant has applied to India's drug regulator seeking marketing authorisation for its anti-viral drug remdesivir, which is being touted ...
Read more: US pharma giant seeks marketing authorisation from India for remdesivir
Read more: US pharma giant seeks marketing authorisation from India for remdesivir
Pharma Reviews: Amid export gloom, pharma shows resilience
India's pharmaceutical exports grew by 0.25% year-on-year basis to US $1,531 million during April 2020, shows pharmaceutical export promotion ...
Read more: Amid export gloom, pharma shows resilience
Read more: Amid export gloom, pharma shows resilience
Pharma Reviews: Western pharma lobby attempts to discredit India
'The enviable position India enjoys in the pharmaceutical sector has made Western drug firms restless'. New Delhi: As India emerges as a production ...
Read more: Western pharma lobby attempts to discredit India
Read more: Western pharma lobby attempts to discredit India
Pharma Reviews: “Vaccine development is a very complex process; developing a vaccine in a year's time is a very ...
Mahavir Lunavat, Group Founder, Pantomath and Co-founder, CorpGini, said, The Indian pharma industry has come a long way over the past 50 plus ...
Read more: “Vaccine development is a very complex process; developing a vaccine in a year's time is a very ...
Read more: “Vaccine development is a very complex process; developing a vaccine in a year's time is a very ...
Pharma Reviews: Pharma companies refine SOPs after Covid-19 cases, deaths in Gujarat
No one is taking it casually," said Viranchi Shah, chairman of Indian Drug Manufacturers' Association (IDMA), Gujarat. For instance, Torrent Pharma too, ...
Read more: Pharma companies refine SOPs after Covid-19 cases, deaths in Gujarat
Read more: Pharma companies refine SOPs after Covid-19 cases, deaths in Gujarat
Pharma Reviews: Coronavirus: Sun Pharma to test pancreatitis drug in COVID-19 patients in India
BENGALURU : Drugmaker Sun Pharmaceutical Industries Ltd said on Friday it has received Indian regulatory approval to start clinical trials of a ...
Read more: Coronavirus: Sun Pharma to test pancreatitis drug in COVID-19 patients in India
Read more: Coronavirus: Sun Pharma to test pancreatitis drug in COVID-19 patients in India
Pharma Reviews: India, US could strike a 'smaller' trade deal in the coming weeks: Indian envoy
India, which is one of the major manufacturers of the drug, has sent several million doses of the HCQ to the US as part of its humanitarian gesture.
Read more: India, US could strike a 'smaller' trade deal in the coming weeks: Indian envoy
Read more: India, US could strike a 'smaller' trade deal in the coming weeks: Indian envoy
Friday, May 29, 2020
Pharma Reviews: Indian manufacturers hail end to export curbs on paracetamol APIs
India makes this drug in both the tablet form and as active pharmaceutical ingredient (API in quickspeak), which is used to make the tablet.
Read more: Indian manufacturers hail end to export curbs on paracetamol APIs
Read more: Indian manufacturers hail end to export curbs on paracetamol APIs
Pharma Reviews: US pharma giant seeks marketing authorisation from India for potential COVID-19 treatment drug
US pharma giant Gilead Sciences has applied to India's drug regulator seeking marketing authorisation for its anti-viral drug remdesivir, which is being ...
Read more: US pharma giant seeks marketing authorisation from India for potential COVID-19 treatment drug
Read more: US pharma giant seeks marketing authorisation from India for potential COVID-19 treatment drug
Pharma Reviews: Our first priority was to save lives, only approach available was the lockdown: Nirmala Sitharaman ...
Expanding on the steps taken towards fighting the virus and the rise of India's PPE and pharma industry, the finance minister said research labs of at ...
Read more: Our first priority was to save lives, only approach available was the lockdown: Nirmala Sitharaman ...
Read more: Our first priority was to save lives, only approach available was the lockdown: Nirmala Sitharaman ...
Pharma Reviews: Slideshow | Gainers & Losers: 10 stocks that moved the most on May 29
Sun Pharma | Shares of Sun Pharmaceutical Industries rose almost 4 percent after receiving approval from the Indian drug regulator for clinical trial of ...
Read more: Slideshow | Gainers & Losers: 10 stocks that moved the most on May 29
Read more: Slideshow | Gainers & Losers: 10 stocks that moved the most on May 29
Pharma Reviews: India is pharmacy of world, provided medicines like hydroxychloroquine to countries, will remain so ...
In similar vein, Indian Pharmaceutical Alliance (IPA) Secretary-General Sudarshan Jain said, "COVID-19 is a great opportunity; any adversity has to be ...
Read more: India is pharmacy of world, provided medicines like hydroxychloroquine to countries, will remain so ...
Read more: India is pharmacy of world, provided medicines like hydroxychloroquine to countries, will remain so ...
Pharma Reviews: Sun Pharma to test pancreatitis drug in Covid-19 patients in India
The company said it has initiated manufacturing of the active pharmaceutical ingredient (API) and the finished product of the drug using technology from ...
Read more: Sun Pharma to test pancreatitis drug in Covid-19 patients in India
Read more: Sun Pharma to test pancreatitis drug in Covid-19 patients in India
Pharma Reviews: India is pharmacy of world, will remain so: MoS Health Choubey
In similar vein, Indian Pharmaceutical Alliance (IPA) Secretary-General Sudarshan Jain said, “COVID-19 is a great opportunity; any adversity has to be ...
Read more: India is pharmacy of world, will remain so: MoS Health Choubey
Read more: India is pharmacy of world, will remain so: MoS Health Choubey
US FDA News: Coronavirus (COVID-19) Update: FDA Takes Steps to Streamline Development of Tests With At-Home Sample Collection
FDA taking steps to further support the development of COVID-19 tests for at-home self-collection by including a voluntary EUA template for at-home sample collection kits to its website.
Read more: Coronavirus (COVID-19) Update: FDA Takes Steps to Streamline Development of Tests With At-Home Sample Collection
Read more: Coronavirus (COVID-19) Update: FDA Takes Steps to Streamline Development of Tests With At-Home Sample Collection
US FDA News: FDA Approves New Option to Treat Heavy Menstrual Bleeding Associated with Fibroids in Women
FDA Approves New Option to Treat Heavy Menstrual Bleeding Associated with Fibroids in Women
Read more: FDA Approves New Option to Treat Heavy Menstrual Bleeding Associated with Fibroids in Women
Read more: FDA Approves New Option to Treat Heavy Menstrual Bleeding Associated with Fibroids in Women
Pharma Reviews: Sun Pharma to test two drugs for treatment of Covid-19, stock up 3.5%
India's largest drug maker Sun Pharmaceutical Industries is getting ready to start the trials on a few drugs that have emerged as potential treatment ...
Read more: Sun Pharma to test two drugs for treatment of Covid-19, stock up 3.5%
Read more: Sun Pharma to test two drugs for treatment of Covid-19, stock up 3.5%
Pharma Reviews: “India will serve as the pharmacy of the world”: Ashwini Kumar Choubey, Minister of State for ...
India can strengthen its dominance in pharma and wellness sectors and serve humanity. Highlighting India's rich history in pharma, he urged the ...
Read more: “India will serve as the pharmacy of the world”: Ashwini Kumar Choubey, Minister of State for ...
Read more: “India will serve as the pharmacy of the world”: Ashwini Kumar Choubey, Minister of State for ...
Pharma Reviews: Amid Coronavirus pandemic, 11 investors show interest in Jet Airways
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company. Delivering products for ...
Read more: Amid Coronavirus pandemic, 11 investors show interest in Jet Airways
Read more: Amid Coronavirus pandemic, 11 investors show interest in Jet Airways
Pharma Reviews: BRIEF-Sun Pharma Gets Indian Regulatory Nod For Nafamostat Study In COVID-19 Patients
May 29 (Reuters) - Sun Pharmaceutical Industries Ltd : * RECEIVES APPROVAL FROM DCGI TO INITIATE CLINICAL TRIAL WITH NAFAMOSTAT IN ...
Read more: BRIEF-Sun Pharma Gets Indian Regulatory Nod For Nafamostat Study In COVID-19 Patients
Read more: BRIEF-Sun Pharma Gets Indian Regulatory Nod For Nafamostat Study In COVID-19 Patients
Pharma Reviews: India's Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patients
Drugmaker Sun Pharmaceutical Industries Ltd said on Friday that it received Indian regulatory approval to start clinical trials of pancreatitis drug ...
Read more: India's Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patients
Read more: India's Sun Pharma to conduct clinical trial of pancreatitis drug in COVID-19 patients
Pharma Reviews: India, US may just strike a 'smaller' industry deal in coming weeks: Indian envoy
India, which is likely one of the main producers of the drug, has despatched a number of million doses of the HCQ to america as a part of its ...
Read more: India, US may just strike a 'smaller' industry deal in coming weeks: Indian envoy
Read more: India, US may just strike a 'smaller' industry deal in coming weeks: Indian envoy
Pharma Reviews: Stock Market Live: Sensex, Nifty turn flat; pharma stocks gain, Vodafone Idea rallies 31%
Stock Market Live: The Indian benchmark indices recovered from day's low and were trading flat led by gains in pharma and realty stocks. Vodafone ...
Read more: Stock Market Live: Sensex, Nifty turn flat; pharma stocks gain, Vodafone Idea rallies 31%
Read more: Stock Market Live: Sensex, Nifty turn flat; pharma stocks gain, Vodafone Idea rallies 31%
Pharma Reviews: Trending stocks: Sun Pharma shares up nearly 1%
Sun Pharmaceutical Industries Ltd. belongs to the Pharma - Indian industry. Read more on. Sun Pharma share price · markets.
Read more: Trending stocks: Sun Pharma shares up nearly 1%
Read more: Trending stocks: Sun Pharma shares up nearly 1%
Thursday, May 28, 2020
Pharma Reviews: COVID-19 testing may go up to about 5 lakh per day by July: Niti Aayog member
Meanwhile, the government said the Indian pharmaceutical industries are trying their best to find a vaccine to beat the virus. “The fight against ...
Read more: COVID-19 testing may go up to about 5 lakh per day by July: Niti Aayog member
Read more: COVID-19 testing may go up to about 5 lakh per day by July: Niti Aayog member
Pharma Reviews: Centre removes restrictions on exports of paracetamol APIs
... paracetamol APIs (active pharmaceutical ingredients) making it export free. ... In April, India had temporarily licensed the export of paracetamol and ...
Read more: Centre removes restrictions on exports of paracetamol APIs
Read more: Centre removes restrictions on exports of paracetamol APIs
Pharma Reviews: Testing may go up to about 5 lakh per day by July: Centre
As of now, India has tested nearly 2,350 samples per million of which ... Meanwhile, the government said the Indian pharmaceutical industries are ...
Read more: Testing may go up to about 5 lakh per day by July: Centre
Read more: Testing may go up to about 5 lakh per day by July: Centre
US FDA News: FDA Alerts Patients and Health Care Professionals to Nitrosamine Impurity Findings in Certain Metformin Extended-Release Products
FDA Alerts Patients and Health Care Professionals to Nitrosamine Impurity Findings in Certain Metformin Extended-Release Products
Read more: FDA Alerts Patients and Health Care Professionals to Nitrosamine Impurity Findings in Certain Metformin Extended-Release Products
Read more: FDA Alerts Patients and Health Care Professionals to Nitrosamine Impurity Findings in Certain Metformin Extended-Release Products
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup May 28, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 28, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 28, 2020
Pharma Reviews: 30 groups in India trying to develop coronavirus vaccines: PSA K Vijay Raghavan
He said, country's science and technology institutions and pharma industry are very strong. He said, about 20 companies are providing diagnostic kits to ...
Read more: 30 groups in India trying to develop coronavirus vaccines: PSA K Vijay Raghavan
Read more: 30 groups in India trying to develop coronavirus vaccines: PSA K Vijay Raghavan
US FDA News: Apotex Corp. Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets 500mg Due to the Detection of N-nitrosodimethylamine (NDMA)
Apotex Corp is voluntarily recalling all lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg within expiry to retail level. Apotex was notified by the U.S. Food and Drug Administration (US FDA) that one lot of Metformin Hydrochloride Extended-Release Tablets, USP was tested and showe
Read more: Apotex Corp. Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets 500mg Due to the Detection of N-nitrosodimethylamine (NDMA)
Read more: Apotex Corp. Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets 500mg Due to the Detection of N-nitrosodimethylamine (NDMA)
US FDA News: FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Disease
FDA approved Tauvid for IV injection, the first drug used to help image a distinctive characteristic of Alzheimer’s disease in the brain called tau pathology. Tauvid is a radioactive diagnostic agent for adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease.
Read more: FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Disease
Read more: FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Disease
Pharma Reviews: Govt lifts ban on export of Paracetamol APIs with immediate effect
The Indian pharmaceutical industry, third largest in the world in terms of volume and fourteenth largest in terms of value, exported formulations made ...
Read more: Govt lifts ban on export of Paracetamol APIs with immediate effect
Read more: Govt lifts ban on export of Paracetamol APIs with immediate effect
US FDA News: Medtronic Recalls HeartWare HVAD Pump Outflow Graft and Outflow Graft Strain Relief Due to Risk of Breaks and Tears During Set Up
These devices are parts of the The HeartWare Ventricular Assist System (HVAD). They attach to the HeartWare HVAD pump which helps the heart deliver blood to the rest of the body. The clamp screws are at risk of breaking when tightening the strain relief clamp and outflow graft tears have been observ
Read more: Medtronic Recalls HeartWare HVAD Pump Outflow Graft and Outflow Graft Strain Relief Due to Risk of Breaks and Tears During Set Up
Read more: Medtronic Recalls HeartWare HVAD Pump Outflow Graft and Outflow Graft Strain Relief Due to Risk of Breaks and Tears During Set Up
Pharma Reviews: Moderna extends lipids deal to boost COVID-19 vaccine output
Pharma sector: Self-reliance a myth, focus on reducing import dependence. China supplies almost one-third of the global requirements. India is also ...
Read more: Moderna extends lipids deal to boost COVID-19 vaccine output
Read more: Moderna extends lipids deal to boost COVID-19 vaccine output
Pharma Reviews: Coronavirus: 30 groups in India are trying to develop vaccine, says NITI Aayog
He added that the All India Council for Technical Education and Council of Scientific and Industrial Research have embarked on a “drug discovery ...
Read more: Coronavirus: 30 groups in India are trying to develop vaccine, says NITI Aayog
Read more: Coronavirus: 30 groups in India are trying to develop vaccine, says NITI Aayog
Pharma Reviews: 30 groups in India trying to develop coronavirus vaccines: PSA K Vijay Raghavan
He said, country's science and technology institutions and pharma industry are very strong. He said, about 20 companies are providing diagnostic kits ...
Read more: 30 groups in India trying to develop coronavirus vaccines: PSA K Vijay Raghavan
Read more: 30 groups in India trying to develop coronavirus vaccines: PSA K Vijay Raghavan
Pharma Reviews: Sun Pharma Q4 net profit declines 37 pc to Rs 399.84 cr
New Delhi, May 27 (PTI) Pharma major Sun Pharmaceutical Industries on ... we have done well and have started gaining market share in India.
Read more: Sun Pharma Q4 net profit declines 37 pc to Rs 399.84 cr
Read more: Sun Pharma Q4 net profit declines 37 pc to Rs 399.84 cr
Pharma Reviews: Coronavirus News Latest Updates | 'Country's science, technology institutions and pharma industry ...
Meanwhile, a massive repatriation process is being carried out by India under phase 2 of Vande Bharat Mission to bring stranded Indians back. Shramik ...
Read more: Coronavirus News Latest Updates | 'Country's science, technology institutions and pharma industry ...
Read more: Coronavirus News Latest Updates | 'Country's science, technology institutions and pharma industry ...
Pharma Reviews: Market LIVE Updates: Indices at day's high, Nifty above 9500; ZEE gains 10%
Sun Pharma & SPARC in licence agreement: Sun Pharma Advanced ... Rupee closes: Indian rupee erased early losses and ended marginally lower ...
Read more: Market LIVE Updates: Indices at day's high, Nifty above 9500; ZEE gains 10%
Read more: Market LIVE Updates: Indices at day's high, Nifty above 9500; ZEE gains 10%
Pharma Reviews: Coronavirus India News LIVE: About 30 groups in India trying to develop COVID-19 vaccine, says ...
Our country's science and technology institutions and pharma industry are very strong. May 28, 2020 03:52 PM IST.
Read more: Coronavirus India News LIVE: About 30 groups in India trying to develop COVID-19 vaccine, says ...
Read more: Coronavirus India News LIVE: About 30 groups in India trying to develop COVID-19 vaccine, says ...
Pharma Reviews: BT Buzz: What added Rs 86000 crore to DRL, Sun Pharma market cap in 2 months?
Glenmark is the first Indian company to receive approval from the Drug Controller General of India (DCGI) to conduct clinical trials of Favipiravir antiviral ...
Read more: BT Buzz: What added Rs 86000 crore to DRL, Sun Pharma market cap in 2 months?
Read more: BT Buzz: What added Rs 86000 crore to DRL, Sun Pharma market cap in 2 months?
Wednesday, May 27, 2020
Pharma Reviews: "Innovation Should Be Given a Boost Through Tax Incentives"
Four Indian pharma companies have just signed a partnership agreement with ... What has been the impact of lockdown on the Indian pharmaceutical ...
Read more: "Innovation Should Be Given a Boost Through Tax Incentives"
Read more: "Innovation Should Be Given a Boost Through Tax Incentives"
Pharma Reviews: BDR Pharmaceuticals move on Remdesivir clone irks Gilead
The Indian company had submitted its application for manufacturing the Covid-19 drug to the Drug Controller General of India (DCGI) last week. By.
Read more: BDR Pharmaceuticals move on Remdesivir clone irks Gilead
Read more: BDR Pharmaceuticals move on Remdesivir clone irks Gilead
Pharma Reviews: Indian IT helps global healthcare firms fight Covid-19
PUNE: Indian IT services providers are playing an important role in helping healthcare and pharmaceutical companies fight the Covid-19 pandemic ...
Read more: Indian IT helps global healthcare firms fight Covid-19
Read more: Indian IT helps global healthcare firms fight Covid-19
Pharma Reviews: 'AI, pharma, speciality chemicals, telecom may lead broader market post COVID'
Recently the stimulus package of Rs 20 lakh crore gave an emotional uplift to the stock market, however, we believe the Indian stock market will follow ...
Read more: 'AI, pharma, speciality chemicals, telecom may lead broader market post COVID'
Read more: 'AI, pharma, speciality chemicals, telecom may lead broader market post COVID'
Pharma Reviews: 1 in 10 Indian jobseeker lost job, most think layoff imminent: Naukri.com report
Jobseekers from the IT, pharma, medical/healthcare and BFSI industries were less impacted by layoffs and salary cuts as compared to their ...
Read more: 1 in 10 Indian jobseeker lost job, most think layoff imminent: Naukri.com report
Read more: 1 in 10 Indian jobseeker lost job, most think layoff imminent: Naukri.com report
Pharma Reviews: Torrent Pharma slips 6% on profit-booking; outlook remains a concern
Though the company remains confident of outperforming Indian pharmaceutical market growth, analysts at Dolat Capital remain wary of the exports ...
Read more: Torrent Pharma slips 6% on profit-booking; outlook remains a concern
Read more: Torrent Pharma slips 6% on profit-booking; outlook remains a concern
Pharma Reviews: Sensex jumps about 1000 points, Nifty tops 9300; Axis Bank rallies 14%
Indian equities soared in the second half of today's session after volatile trade in the morning. ... Sun Pharmaceutical lost nearly 2%, becoming the worst Nifty stock, after the ... Nifty Pharma also bucked the broader market trend.
Read more: Sensex jumps about 1000 points, Nifty tops 9300; Axis Bank rallies 14%
Read more: Sensex jumps about 1000 points, Nifty tops 9300; Axis Bank rallies 14%
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup May 27, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 27, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 27, 2020
US FDA News: Coronavirus (COVID-19) Update: FDA Provides New Tool to Aid Development and Evaluation of Diagnostic Tests That Detect SARS-CoV-2 Infection
FDA new step to support the evaluation of diagnostic tests for COVID-19, by providing a SARS-CoV-2 reference panel. Reference panels are needed to ensure the quality of the tests, validation of new assays, test calibration, and monitoring of assay performance.
Read more: Coronavirus (COVID-19) Update: FDA Provides New Tool to Aid Development and Evaluation of Diagnostic Tests That Detect SARS-CoV-2 Infection
Read more: Coronavirus (COVID-19) Update: FDA Provides New Tool to Aid Development and Evaluation of Diagnostic Tests That Detect SARS-CoV-2 Infection
US FDA News: Use the Correct Cycle and Compatible N95 Respirators When Decontaminating Respirators with STERRAD Sterilization Systems - Letter to Health Care Providers
The FDA is reminding reprocessing staff in health care facilities to use the correct decontamination cycle associated with certain models of the ASP STERRAD Sterilization Systems to decontaminate compatible NN95 respirators.
Read more: Use the Correct Cycle and Compatible N95 Respirators When Decontaminating Respirators with STERRAD Sterilization Systems - Letter to Health Care Providers
Read more: Use the Correct Cycle and Compatible N95 Respirators When Decontaminating Respirators with STERRAD Sterilization Systems - Letter to Health Care Providers
Pharma Reviews: Pharma sector: Self-reliance a myth, focus on reducing import dependence
... the pharma industry feels the concept is a myth in a connected world and India ... Indian Immunologicals Ltd MD K Anand Kumar called for stronger ...
Read more: Pharma sector: Self-reliance a myth, focus on reducing import dependence
Read more: Pharma sector: Self-reliance a myth, focus on reducing import dependence
Pharma Reviews: View: Distributing the vaccine
Manufacturing it in large enough quantities to supply the entire world ... Indian pharma companies, led by CiplaNSE -1.12 %, saved the world from ...
Read more: View: Distributing the vaccine
Read more: View: Distributing the vaccine
Pharma Reviews: Stocks in the news: Titan, Kotak Bank, Sun Pharma
Financial Results: Dabur, Heritage Foods, India Grid Trust, Aditya Birla Fashion, Compucom Software, Sun Pharmaceutical, Quess Corp, ...
Read more: Stocks in the news: Titan, Kotak Bank, Sun Pharma
Read more: Stocks in the news: Titan, Kotak Bank, Sun Pharma
Pharma Reviews: The business plan for Make In India 2.0
The pharma industry saw red last year when China suddenly increased the prices of pharmaceutical intermediates by 30-40%. Intermediates are key ...
Read more: The business plan for Make In India 2.0
Read more: The business plan for Make In India 2.0
Pharma Reviews: Chronicles of COVID-19
But just as India's pharma sector is paying a heavy price for being dependent on one country (China) for key active pharmaceutical ingredients, the ...
Read more: Chronicles of COVID-19
Read more: Chronicles of COVID-19
Pharma Reviews: Glenmark Pharma to study potential Covid-19 drug combination
... to enroll 158 hospitalized patients with moderate COVID-19, the company said. ... Glenmark is also conducting clinical trials in India of just favipiravir as a ... Another Indian drugmaker - Strides Pharma - is also set to begin clinical ...
Read more: Glenmark Pharma to study potential Covid-19 drug combination
Read more: Glenmark Pharma to study potential Covid-19 drug combination
Tuesday, May 26, 2020
US FDA News: FDA Approves Only Drug in U.S. to Treat Severe Malaria
FDA has approved artesunate for injection to treat severe malaria in adult and pediatric patients.
Read more: FDA Approves Only Drug in U.S. to Treat Severe Malaria
Read more: FDA Approves Only Drug in U.S. to Treat Severe Malaria
US FDA News: FDA Approves First Treatment for a Form of Bladder Dysfunction in Pediatric Patients as Young as 2 Years of Age
FDA Approves First Treatment for a Form of Bladder Dysfunction in Pediatric Patients as Young as 2 Years of Age
Read more: FDA Approves First Treatment for a Form of Bladder Dysfunction in Pediatric Patients as Young as 2 Years of Age
Read more: FDA Approves First Treatment for a Form of Bladder Dysfunction in Pediatric Patients as Young as 2 Years of Age
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup May 26, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 26, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 26, 2020
Pharma Reviews: Pharmacy and Biotechnology Students of Chandigarh University Gets Placed in Top ...
Attributing to the growth of Indian Pharmaceutical Industry, the number of jobs in the sector has seen a big surge which can be verified from the fact ...
Read more: Pharmacy and Biotechnology Students of Chandigarh University Gets Placed in Top ...
Read more: Pharmacy and Biotechnology Students of Chandigarh University Gets Placed in Top ...
Pharma Reviews: Think big to draw firms away from China: Telangana minister KT Rama Rao
Dr Reddy's Laboratories chairman and Indian Pharmaceutical Alliance president Satish Reddy said that for the pharma industry to thrive in the country ...
Read more: Think big to draw firms away from China: Telangana minister KT Rama Rao
Read more: Think big to draw firms away from China: Telangana minister KT Rama Rao
Pharma Reviews: India has surplus capacity, may allow export of masks in a week: Sources
India may allow export of certain category of face masks soon as the ... of Indian Medical Device Industry (AiMeD), had written a letter to pharma ...
Read more: India has surplus capacity, may allow export of masks in a week: Sources
Read more: India has surplus capacity, may allow export of masks in a week: Sources
Pharma Reviews: The world needs pharmaceuticals from China and India to beat COVID-19
Yet these companies and the pharmaceutical industry as a whole rely on global supply chains. And China and India play key roles in the supply of ...
Read more: The world needs pharmaceuticals from China and India to beat COVID-19
Read more: The world needs pharmaceuticals from China and India to beat COVID-19
Pharma Reviews: India invites Rs 70000 Cr investment in medical devices sector: AiMeD
Japanese companies invited to invest in Indian Pharmaceutical and Medical Devices industry. A webinar on 'Medical Devices and API sector: ...
Read more: India invites Rs 70000 Cr investment in medical devices sector: AiMeD
Read more: India invites Rs 70000 Cr investment in medical devices sector: AiMeD
Monday, May 25, 2020
Pharma Reviews: Trump wants to make US pharma great again; Indian drug makers not panicking yet
India currently has roughly a 20 percent market share of generic drugs globally. Indian companies supply 4 out of 10 generic drugs consumed by ...
Read more: Trump wants to make US pharma great again; Indian drug makers not panicking yet
Read more: Trump wants to make US pharma great again; Indian drug makers not panicking yet
Pharma Reviews: India Invites Investments of Rs 70000 Cr in Medical Devices Sector & Woos Japanese ...
Vaghela, Secretary, Pharmaceuticals presented the sectoral view and the investment opportunities in the pharmaceutical and medical device industry in ...
Read more: India Invites Investments of Rs 70000 Cr in Medical Devices Sector & Woos Japanese ...
Read more: India Invites Investments of Rs 70000 Cr in Medical Devices Sector & Woos Japanese ...
Pharma Reviews: Face scan, open doors, zig-zag seating, doctor-on-call: Pharma firms redefine Covid workplace
... planning to re-open the workplace and manufacturing sites,” said Ashok Madan, executive director, Indian Drug Manufacturers Association (IDMA), ...
Read more: Face scan, open doors, zig-zag seating, doctor-on-call: Pharma firms redefine Covid workplace
Read more: Face scan, open doors, zig-zag seating, doctor-on-call: Pharma firms redefine Covid workplace
Pharma Reviews: TOI conclave to help design Telangana's post-lockdown future
... Indian Pharmaceutical Alliance president and Dr Reddy's Laboratories chairman Satish Reddy, Shantha Biotechnics founder KI Varaprasad Reddy, ...
Read more: TOI conclave to help design Telangana's post-lockdown future
Read more: TOI conclave to help design Telangana's post-lockdown future
Pharma Reviews: Mutual Funds: Pharma fund, International funds and SIP queries answered
The international funds provide some level of diversification to the investors as the majority of the equity funds in India are exposed to the Indian market ...
Read more: Mutual Funds: Pharma fund, International funds and SIP queries answered
Read more: Mutual Funds: Pharma fund, International funds and SIP queries answered
Pharma Reviews: Covid-19 effect: Time for Made-in-India tag to go global
“China is a leading supplier of basic chemicals and active pharmaceutical ingredients (APIs) by volume to the global market. Indian companies focus on ...
Read more: Covid-19 effect: Time for Made-in-India tag to go global
Read more: Covid-19 effect: Time for Made-in-India tag to go global
Pharma Reviews: Covid-19 crisis prompts India to look for global partners in health care
As India shifts its focus to the pharmaceutical and medical devices industries amid the Covid-19 pandemic, it is actively reaching out to several ...
Read more: Covid-19 crisis prompts India to look for global partners in health care
Read more: Covid-19 crisis prompts India to look for global partners in health care
Saturday, May 23, 2020
Pharma Reviews: Japanese companies invited to invest in Indian Pharma, Medical Devices industry
... Secretary, Pharmaceuticals presented the sectoral view and the investment opportunities in the pharmaceutical and medical device industry in India ...
Read more: Japanese companies invited to invest in Indian Pharma, Medical Devices industry
Read more: Japanese companies invited to invest in Indian Pharma, Medical Devices industry
Pharma Reviews: Covid-19 Hit India's Pharma Sector, But it Can Use Shortage of Chinese APIs to Emerge as a ...
India's global export of essential medicines took a leap when Cipla — a noted Indian pharmaceutical firm — sold HIV medicines in sub-Saharan Africa ...
Read more: Covid-19 Hit India's Pharma Sector, But it Can Use Shortage of Chinese APIs to Emerge as a ...
Read more: Covid-19 Hit India's Pharma Sector, But it Can Use Shortage of Chinese APIs to Emerge as a ...
Pharma Reviews: Cipla and Hetero seek clinical trial waiver for Remdesivir
New Delhi: Indian pharmaceutical companies have taken a step forward ... remdesivir, a drug touted as a potential treatment for Covid-19, to India.
Read more: Cipla and Hetero seek clinical trial waiver for Remdesivir
Read more: Cipla and Hetero seek clinical trial waiver for Remdesivir
Pharma Reviews: BioSpectrum Webinar explores strategies for 'Make in India' in LifeSciences- post lockdown!
For example, the current dependency of Indian pharma companies on ... Partnerships & Entrepreneurship Development, Biotechnology Industry ...
Read more: BioSpectrum Webinar explores strategies for 'Make in India' in LifeSciences- post lockdown!
Read more: BioSpectrum Webinar explores strategies for 'Make in India' in LifeSciences- post lockdown!
Pharma Reviews: From Disruptive Covid Chaos, Comes an Opportunity for India's Pharmaceutical Industry
COVID 19 has brought to the fore and fused the subjects of science, sustainability, and social issues. On May 14, 2020 the Indian Council for Medical ...
Read more: From Disruptive Covid Chaos, Comes an Opportunity for India's Pharmaceutical Industry
Read more: From Disruptive Covid Chaos, Comes an Opportunity for India's Pharmaceutical Industry
Pharma Reviews: Prakash Bhosale's New Book In Collaboration With SPDS
The book will be published by Society For Pharmaceutical Dissolution ... has been working with Indian Pharmaceutical Industry in various positions for ...
Read more: Prakash Bhosale's New Book In Collaboration With SPDS
Read more: Prakash Bhosale's New Book In Collaboration With SPDS
Friday, May 22, 2020
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup May 22, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 22, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 22, 2020
US FDA News: Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Super Potency
Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. The products are being recalled because our testing has found these lots to be superpotent. The product may have up to 115.0% of the labeled amo
Read more: Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Super Potency
Read more: Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Super Potency
Pharma Reviews: Understanding the coming challenges to India's pharma sector
India should use the likely shortage of Chinese APIs to its advantage and become a dominant player in the world pharma market. COVID, Medical ...
Read more: Understanding the coming challenges to India's pharma sector
Read more: Understanding the coming challenges to India's pharma sector
Pharma Reviews: Watch | COVID-19 Bulletin: Another Indian Firm Gets Approval for Trials of Potential COVID Drug
Earlier this month, Glenmark Pharmaceuticals became the first pharma company in India to get the nod to conduct trials on the drug Favipiravir. 3 ...
Read more: Watch | COVID-19 Bulletin: Another Indian Firm Gets Approval for Trials of Potential COVID Drug
Read more: Watch | COVID-19 Bulletin: Another Indian Firm Gets Approval for Trials of Potential COVID Drug
Pharma Reviews: IPA reviews activities undertaken to strengthen pharmacy education and profession during two ...
The Indian Pharmaceutical Association (IPA), with its widespread network of ... Industry Pharmacy Division, Community Pharmacy Division, Regulatory ...
Read more: IPA reviews activities undertaken to strengthen pharmacy education and profession during two ...
Read more: IPA reviews activities undertaken to strengthen pharmacy education and profession during two ...
Pharma Reviews: Crisis Raises Allure of Drug, Consumer Stocks as Top India Bets
The “front-line companies in pharma and consumer spending are likely to ... is bullish on Indian drugmakers for a gamut of reasons -- the industry's ...
Read more: Crisis Raises Allure of Drug, Consumer Stocks as Top India Bets
Read more: Crisis Raises Allure of Drug, Consumer Stocks as Top India Bets
Pharma Reviews: Only digital adoption can help firms thrive: SAP's Deb Deep Sengupta
Of the sectors that will recover quickly, he said the pharma industry has an ... SAP India is the second largest centre for the company, with 12,893 ...
Read more: Only digital adoption can help firms thrive: SAP's Deb Deep Sengupta
Read more: Only digital adoption can help firms thrive: SAP's Deb Deep Sengupta
Pharma Reviews: Rajan says migrant workers need money for vegetables, cooking oil, shelter; foodgrains not enough
The company has received approval from the Indian drug authorities for conducting human studies on favipiravir in the country, a Strides Pharma ...
Read more: Rajan says migrant workers need money for vegetables, cooking oil, shelter; foodgrains not enough
Read more: Rajan says migrant workers need money for vegetables, cooking oil, shelter; foodgrains not enough
Pharma Reviews: Indian pharmaceutical company Strides to test potential COVID-19 drug: Why Favipiravir may treat ...
Bengaluru: Indian pharmaceutical company Strides Pharma Science Ltd on Thursday said that it has received approval from the Drug Controller ...
Read more: Indian pharmaceutical company Strides to test potential COVID-19 drug: Why Favipiravir may treat ...
Read more: Indian pharmaceutical company Strides to test potential COVID-19 drug: Why Favipiravir may treat ...
Thursday, May 21, 2020
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup May 21, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 21, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 21, 2020
US FDA News: Coronavirus (COVID-19) Update: FDA Provides Promised Transparency for Antibody Tests
The FDA has posted a list of antibody tests that are no longer being offered under the March 16, 2020 Policy, which is sometimes called the “notification list.”
Read more: Coronavirus (COVID-19) Update: FDA Provides Promised Transparency for Antibody Tests
Read more: Coronavirus (COVID-19) Update: FDA Provides Promised Transparency for Antibody Tests
US FDA News: FDA Releases Report on Investigation into Fall 2019 Outbreaks of Illnesses Tied to Romaine Lettuce
FDA released the findings of an investigation into the Fall 2019 Outbreaks of Illnesses Tied to Romaine Lettuce
Read more: FDA Releases Report on Investigation into Fall 2019 Outbreaks of Illnesses Tied to Romaine Lettuce
Read more: FDA Releases Report on Investigation into Fall 2019 Outbreaks of Illnesses Tied to Romaine Lettuce
Pharma Reviews: US pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India
"On the basis of approvals granted by USFDA or any other reputed regulator, the Indian regulator can approve the drug by waiving off clinical trials in ...
Read more: US pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India
Read more: US pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India
Pharma Reviews: Cyclone Amphan wreaks havoc in WB, Odisha; FM's advice for India Inc.
... causing heavy rainfall, uprooting trees and swamping homes and farmlands; Indian pharmaceutical company Strides Pharma Science Ltd said on ...
Read more: Cyclone Amphan wreaks havoc in WB, Odisha; FM's advice for India Inc.
Read more: Cyclone Amphan wreaks havoc in WB, Odisha; FM's advice for India Inc.
Pharma Reviews: Why India saw only 4 pharma products launched in April, its lowest count ever
New Delhi: The coronavirus crisis and subsequent lockdown has impacted every industry in India, including the one industry needed to fight the ...
Read more: Why India saw only 4 pharma products launched in April, its lowest count ever
Read more: Why India saw only 4 pharma products launched in April, its lowest count ever
Pharma Reviews: Power, IT, insurance stocks top buys of ICICI Pru AMC amid April rebound
“India is known mostly for pharmaceutical companies, which are in the generic space. The demand for cheaper drugs will not go away, said Raunak ...
Read more: Power, IT, insurance stocks top buys of ICICI Pru AMC amid April rebound
Read more: Power, IT, insurance stocks top buys of ICICI Pru AMC amid April rebound
Pharma Reviews: A new strategy is needed to rejuvenate India's healthcare sector
The structure of India's healthcare industry means that India now needs to build on its competitive position in the Pharmaceutical and Biotechnology ...
Read more: A new strategy is needed to rejuvenate India's healthcare sector
Read more: A new strategy is needed to rejuvenate India's healthcare sector
Pharma Reviews: IndiGo, SpiceJet gear up for post-lockdown operations
Gurgaon-headquartered IndiGo, India's largest airline by passengers carried ... Indian pharmaceutical company Strides Pharma Science Ltd said on ...
Read more: IndiGo, SpiceJet gear up for post-lockdown operations
Read more: IndiGo, SpiceJet gear up for post-lockdown operations
Pharma Reviews: Stock Market Highlights: Sensex, Nifty end with lacklustre gains; Bajaj twins drag, ITC top gainer
Stock Market Highlights: Indian equity indices ended with gains for the third ... Strides Pharma to conduct trials in India for potential COVID-19 drug.
Read more: Stock Market Highlights: Sensex, Nifty end with lacklustre gains; Bajaj twins drag, ITC top gainer
Read more: Stock Market Highlights: Sensex, Nifty end with lacklustre gains; Bajaj twins drag, ITC top gainer
Pharma Reviews: Strides Pharma to conduct trials in India for potential Covid-19 drug
BENGALURU: Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has got regulatory approval to conduct clinical trials of ...
Read more: Strides Pharma to conduct trials in India for potential Covid-19 drug
Read more: Strides Pharma to conduct trials in India for potential Covid-19 drug
Pharma Reviews: Pharma, telecom stocks shine on Covid-hit Street
Indian stock markets are down over 20 per cent from February 19 but there are some outliers which have defied the weak market trend. About 15 of the ...
Read more: Pharma, telecom stocks shine on Covid-hit Street
Read more: Pharma, telecom stocks shine on Covid-hit Street
Pharma Reviews: Coronavirus India News LIVE Updates: UP's Barabanki emerges as new COVID-19 hotspot
Indian pharmaceutical company Strides Pharma Science Ltd. today said it has obtained regulatory approval to conduct clinical trials of antiviral drug ...
Read more: Coronavirus India News LIVE Updates: UP's Barabanki emerges as new COVID-19 hotspot
Read more: Coronavirus India News LIVE Updates: UP's Barabanki emerges as new COVID-19 hotspot
Pharma Reviews: Trump's focus on local drugs not immediate concern: Indian pharma industry
Another drug maker said that it would take time for the company to scale up manufacturing capacities. Pharma industry lobby groups in India said that ...
Read more: Trump's focus on local drugs not immediate concern: Indian pharma industry
Read more: Trump's focus on local drugs not immediate concern: Indian pharma industry
Pharma Reviews: Dr Reddy's Q4 ship steady, but margin expansion is key to profitability
This is a bit worrying also considering that the domestic market has shown high digit growth considering Indian pharma market numbers.
Read more: Dr Reddy's Q4 ship steady, but margin expansion is key to profitability
Read more: Dr Reddy's Q4 ship steady, but margin expansion is key to profitability
Pharma Reviews: From Pune to Chennai: These are India's best manufacturing hubs
The region is a significant contributor to the IT, pharma, biotech, medical devices, aerospace, defence and ESDM sectors. Hyderabad accounts for a third ...
Read more: From Pune to Chennai: These are India's best manufacturing hubs
Read more: From Pune to Chennai: These are India's best manufacturing hubs
Wednesday, May 20, 2020
US FDA News: Biota Biosciences Issues Voluntary Nationwide Recall of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables Because They Were Marketed Without FDA Approval
Biota Biosciences is voluntarily recalling the following lots in the table below of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables to the customer level.
Read more: Biota Biosciences Issues Voluntary Nationwide Recall of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables Because They Were Marketed Without FDA Approval
Read more: Biota Biosciences Issues Voluntary Nationwide Recall of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables Because They Were Marketed Without FDA Approval
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup May 20, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 20, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 20, 2020
Pharma Reviews: Stock Market Live: Indices off day's high; Nifty around 8950 as FMCG, pharma stocks support
Rupee Update: The Indian currency opened stronger for the second straight day on Wednesday in-line with the equity market. The Indian rupee opened ...
Read more: Stock Market Live: Indices off day's high; Nifty around 8950 as FMCG, pharma stocks support
Read more: Stock Market Live: Indices off day's high; Nifty around 8950 as FMCG, pharma stocks support
Pharma Reviews: Covid-19: When will Indian real estate sector recover?
Post pandemic flattening, sectors such as pharma, healthcare will witness stronger cashflows while industrial segments such as manufacturing and ...
Read more: Covid-19: When will Indian real estate sector recover?
Read more: Covid-19: When will Indian real estate sector recover?
Pharma Reviews: 'Coronavirus is not a pandemic in the country': Pakistan's Supreme Court lifts restrictions, orders all ...
Following the coronavirus crisis, Pakistan's pharmaceutical industry had demanded that the ban on Indian medicines and medicinal raw material ...
Read more: 'Coronavirus is not a pandemic in the country': Pakistan's Supreme Court lifts restrictions, orders all ...
Read more: 'Coronavirus is not a pandemic in the country': Pakistan's Supreme Court lifts restrictions, orders all ...
Pharma Reviews: [Exclusive] Fake Drugs Are A Billion Dollar Problem, Killing Thousands Every Year: President of ...
On the issue of fake pharmaceutical products, he said, “Pharmaceuticals ... How often does Indian pharma industry fall prey to sub-standardised or ...
Read more: [Exclusive] Fake Drugs Are A Billion Dollar Problem, Killing Thousands Every Year: President of ...
Read more: [Exclusive] Fake Drugs Are A Billion Dollar Problem, Killing Thousands Every Year: President of ...
Pharma Reviews: Companies Keen To Ditch China, How India Can Become An Alternative?
Multinational companies have shown interest to move out of China, its time for ... India's Pharma industry is also highly dependent on Chinese imports.
Read more: Companies Keen To Ditch China, How India Can Become An Alternative?
Read more: Companies Keen To Ditch China, How India Can Become An Alternative?
Pharma Reviews: Traders' Diary: Nifty may fall to 8700-8500 level in near term
Siemens India's promoter group rejigged its holding in the company as the German parent ... Here are the top gainers and losers in the pharma sector.
Read more: Traders' Diary: Nifty may fall to 8700-8500 level in near term
Read more: Traders' Diary: Nifty may fall to 8700-8500 level in near term
Tuesday, May 19, 2020
US FDA News: USDA, FDA Strengthen U.S. Food Supply Chain Protections
The following statement is attributed to Mindy Brashears, Ph.D., USDA Under Secretary for Food Safety, and Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response
Read more: USDA, FDA Strengthen U.S. Food Supply Chain Protections
Read more: USDA, FDA Strengthen U.S. Food Supply Chain Protections
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup May 19, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 19, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 19, 2020
US FDA News: Coronavirus (COVID-19) Update: FDA Collaborations Promote Rigorous Analyses of Real-World Data to Inform Pandemic Response
FDA is applying data from diverse sources to inform its response to COVID-19. FDA has entered into an agreement with Aetion to collaborate on advanced analytical techniques to answer urgent COVID-19 research questions.
Read more: Coronavirus (COVID-19) Update: FDA Collaborations Promote Rigorous Analyses of Real-World Data to Inform Pandemic Response
Read more: Coronavirus (COVID-19) Update: FDA Collaborations Promote Rigorous Analyses of Real-World Data to Inform Pandemic Response
Monday, May 18, 2020
Pharma Reviews: Huge scope for Indian pharma as FDA eases drug scrutiny over shortage in US
Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance (IPA), felt that the pharma sector has worked on improving compliance and ...
Read more: Huge scope for Indian pharma as FDA eases drug scrutiny over shortage in US
Read more: Huge scope for Indian pharma as FDA eases drug scrutiny over shortage in US
Pharma Reviews: Trending stocks: Torrent Pharmaceuticals shares rise nearly 2%
Torrent Pharmaceuticals Ltd. belongs to the Pharma - Indian industry. Read more on. torrent pharma share price · markets.
Read more: Trending stocks: Torrent Pharmaceuticals shares rise nearly 2%
Read more: Trending stocks: Torrent Pharmaceuticals shares rise nearly 2%
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup May 18, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 18, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 18, 2020
Sunday, May 17, 2020
Pharma Reviews: Footwear, textiles, pharma, electronics in Centre's list of sectors to push self reliance
In crucial sectors like pharmaceuticals, industry executives previously told The Indian Express that India used to be self-sufficient in producing the key ...
Read more: Footwear, textiles, pharma, electronics in Centre's list of sectors to push self reliance
Read more: Footwear, textiles, pharma, electronics in Centre's list of sectors to push self reliance
Pharma Reviews: Cipla working on multiple therapies to fight spread of coronavirus
Also, the OTC list for medicines in India is a smaller one, and therefore ... This may put pressure on the overall growth of the Indian pharma market at ...
Read more: Cipla working on multiple therapies to fight spread of coronavirus
Read more: Cipla working on multiple therapies to fight spread of coronavirus
Pharma Reviews: After China, India reaches out to LAC, African countries with medicine diplomacy
Including others forms of medical assistance, India will supply Covid-related stuff ... "In a coordinated response involving several branches of government and multiple private sector pharma companies, India was able to supply, after ...
Read more: After China, India reaches out to LAC, African countries with medicine diplomacy
Read more: After China, India reaches out to LAC, African countries with medicine diplomacy
Saturday, May 16, 2020
Pharma Reviews: New initiative in US-India partnership, courtesy Covid
The US has already identified Indian pharmaceutical companies as one of ... the importance of India and its vast experience in the pharma industry.
Read more: New initiative in US-India partnership, courtesy Covid
Read more: New initiative in US-India partnership, courtesy Covid
Pharma Reviews: Carlyle and former Mylan top executive in talks to buy Ra Chem Pharma from Micro Labs
Days after acquiring India's largest pure-play animal healthcare company , Bengaluru based Sequent Scientific Ltd, The Carlyle Group is close to ...
Read more: Carlyle and former Mylan top executive in talks to buy Ra Chem Pharma from Micro Labs
Read more: Carlyle and former Mylan top executive in talks to buy Ra Chem Pharma from Micro Labs
Pharma Reviews: Day 4: Nirmala Sitharaman makes announcements on structural reforms
This will be strictly for medical isotopes only. We have see how strong India's pharma sector is and how Indian medicines were sent the world over ...
Read more: Day 4: Nirmala Sitharaman makes announcements on structural reforms
Read more: Day 4: Nirmala Sitharaman makes announcements on structural reforms
Pharma Reviews: USFDA Looks for Ways to Speed up Plant Inspections
India's pharma exports to the US are estimated at $20 billion. The FDA typically sends investigators to inspect a drug company's manufacturing facilities ...
Read more: USFDA Looks for Ways to Speed up Plant Inspections
Read more: USFDA Looks for Ways to Speed up Plant Inspections
US FDA News: Coronavirus (COVID-19) Update: FDA Authorizes First Standalone At-Home Sample Collection Kit That Can Be Used With Certain Authorized Tests
FDA informs public about an emergency use authorization for an at-home collection kit for use with multiple authorized COVID-19 diagnostic tests
Read more: Coronavirus (COVID-19) Update: FDA Authorizes First Standalone At-Home Sample Collection Kit That Can Be Used With Certain Authorized Tests
Read more: Coronavirus (COVID-19) Update: FDA Authorizes First Standalone At-Home Sample Collection Kit That Can Be Used With Certain Authorized Tests
Friday, May 15, 2020
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup May 15, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 15, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 15, 2020
US FDA News: FDA Approves First Drug for Fourth-Line Treatment of Advanced Gastrointestinal Stromal Tumors
FDA has approved Qinlock (ripretinib) tablets as the first new drug specifically approved as a fourth-line treatment for advanced gastrointestinal stromal tumor (GIST), a type of tumor that originates in the gastrointestinal tract.
Read more: FDA Approves First Drug for Fourth-Line Treatment of Advanced Gastrointestinal Stromal Tumors
Read more: FDA Approves First Drug for Fourth-Line Treatment of Advanced Gastrointestinal Stromal Tumors
Pharma Reviews: PMFAI Appeals to Government for Various Measures to Support Indian Pesticide Industry
Recently the Department of Pharmaceuticals has declared an incentive scheme for pharma sector of Rs.10,000 crores for strengthening of domestic ...
Read more: PMFAI Appeals to Government for Various Measures to Support Indian Pesticide Industry
Read more: PMFAI Appeals to Government for Various Measures to Support Indian Pesticide Industry
Pharma Reviews: Affordable access to Covid-19 drugs: Are voluntary patent licences here to stay?
... voluntary patent licensing agreements with four Indian pharmaceutical companies, giving them rights to manufacture and sell the drug Remdesivir to ...
Read more: Affordable access to Covid-19 drugs: Are voluntary patent licences here to stay?
Read more: Affordable access to Covid-19 drugs: Are voluntary patent licences here to stay?
Pharma Reviews: Share Market Live Highlights: Sensex, Nifty end the week in red; auto, bank stocks drag
Closing Bell: Indian market ends in the red for the second straight week; ... On the sectoral front, auto, bank, IT, pharma remained under pressure, ...
Read more: Share Market Live Highlights: Sensex, Nifty end the week in red; auto, bank stocks drag
Read more: Share Market Live Highlights: Sensex, Nifty end the week in red; auto, bank stocks drag
US FDA News: Summitt Labs Issues Voluntary Nationwide Recall of KORE ORGANIC Watermelon CBD Oil Due to High Lead Results
Summitt Labs is voluntarily recalling Batch#730 Lot#K018 of KORE ORGANIC Watermelon CBD Oil Tincture, 30 ml bottle, 15mg 450x to the consumer level. The Florida Department of Agriculture and Consumer Services tested a random sample and found the product to contain lead levels at 4.7 ppm.
Read more: Summitt Labs Issues Voluntary Nationwide Recall of KORE ORGANIC Watermelon CBD Oil Due to High Lead Results
Read more: Summitt Labs Issues Voluntary Nationwide Recall of KORE ORGANIC Watermelon CBD Oil Due to High Lead Results
Pharma Reviews: Trending stocks: Aurobindo Pharma shares down 1%
Aurobindo Pharma Ltd. belongs to the Pharma - Indian industry. Read more on. Aurobindo Pharma share price · markets.
Read more: Trending stocks: Aurobindo Pharma shares down 1%
Read more: Trending stocks: Aurobindo Pharma shares down 1%
Thursday, May 14, 2020
Pharma Reviews: Stocks in the news: Cipla, GMR Infra, Aurobindo Pharma, Indiabulls Real Estate and Ashok leyland
Asian Paints: Instead of slashing pay and jobs — standard industry responses to the current demand destruction — India's biggest paints maker is ...
Read more: Stocks in the news: Cipla, GMR Infra, Aurobindo Pharma, Indiabulls Real Estate and Ashok leyland
Read more: Stocks in the news: Cipla, GMR Infra, Aurobindo Pharma, Indiabulls Real Estate and Ashok leyland
Pharma Reviews: Indian e-commerce on its path to recovery; regains 30% of pre-lockdown order: Report
... recovered 30 per cent, consumer electronic appliances have a recovery rate of 35 per cent while online cosmetics and e-pharma sector has logged ...
Read more: Indian e-commerce on its path to recovery; regains 30% of pre-lockdown order: Report
Read more: Indian e-commerce on its path to recovery; regains 30% of pre-lockdown order: Report
Pharma Reviews: Health groups ask India to rescind Gilead's patents for COVID-19 drug remdesivir
"It is imperative at a time like this that no monopoly rights be granted, so that more manufacturers can produce the drug to be made available to all the ...
Read more: Health groups ask India to rescind Gilead's patents for COVID-19 drug remdesivir
Read more: Health groups ask India to rescind Gilead's patents for COVID-19 drug remdesivir
Pharma Reviews: India: Government Lifts Restrictions On Export Of 24 API Pharma Ingredients With Immediate Effect
The Indian Pharmaceutical Alliance (IPA), which represents the country's biggest drug makers, and the Indian Drugs' Manufacturer's Association ...
Read more: India: Government Lifts Restrictions On Export Of 24 API Pharma Ingredients With Immediate Effect
Read more: India: Government Lifts Restrictions On Export Of 24 API Pharma Ingredients With Immediate Effect
Pharma Reviews: Coronavirus pandemic | Demand for API specialists, regulatory experts rises in pharma sector
API refers to the active ingredient used in a pharmaceutical drug. ... A senior pharma executive at a large Indian drug maker told Moneycontrol that ...
Read more: Coronavirus pandemic | Demand for API specialists, regulatory experts rises in pharma sector
Read more: Coronavirus pandemic | Demand for API specialists, regulatory experts rises in pharma sector
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup May 14, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 14, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 14, 2020
US FDA News: Coronavirus (COVID-19) Update: FDA Informs Public About Possible Accuracy Concerns with Abbott ID NOW Point-of-Care Test
FDA informs public about early data that suggest potential inaccurate results from using the Abbott ID NOW point of care test to diagnose COVID-19.
Read more: Coronavirus (COVID-19) Update: FDA Informs Public About Possible Accuracy Concerns with Abbott ID NOW Point-of-Care Test
Read more: Coronavirus (COVID-19) Update: FDA Informs Public About Possible Accuracy Concerns with Abbott ID NOW Point-of-Care Test
US FDA News: Coronavirus (COVID-19) Update: Federal judge enters temporary injunction against Xephyr LLC doing business as N-Ergetics, preventing sale of Colloidal Silver Products for COVID-19
Federal judge enters temporary injunction against Xephyr LLC doing business as N-Ergetics, preventing sale of Colloidal Silver Products for COVID-19
Read more: Coronavirus (COVID-19) Update: Federal judge enters temporary injunction against Xephyr LLC doing business as N-Ergetics, preventing sale of Colloidal Silver Products for COVID-19
Read more: Coronavirus (COVID-19) Update: Federal judge enters temporary injunction against Xephyr LLC doing business as N-Ergetics, preventing sale of Colloidal Silver Products for COVID-19
US FDA News: FDA issues warning letters to two breast implant manufacturers as part of ongoing efforts to protect patients
FDA issued warning letters to two breast implant manufacturers for failure to comply with various regulatory requirements.
Read more: FDA issues warning letters to two breast implant manufacturers as part of ongoing efforts to protect patients
Read more: FDA issues warning letters to two breast implant manufacturers as part of ongoing efforts to protect patients
Wednesday, May 13, 2020
Pharma Reviews: View : How a right mix of localism with globalism can further India's economic cause
But, remember, when Nehru created the public sector Indian Drugs and Pharmaceuticals Ltd (IDPL) to make India self-sufficient in pharma, he failed ...
Read more: View : How a right mix of localism with globalism can further India's economic cause
Read more: View : How a right mix of localism with globalism can further India's economic cause
Pharma Reviews: Creador frontrunner to buy Tata Capital's stake in packaging co
It invested in Intas Biopharmaceuticals, Novalead Pharma, Amanta ... In last couple of years, Packaging industry in India has seen large PE deals such ...
Read more: Creador frontrunner to buy Tata Capital's stake in packaging co
Read more: Creador frontrunner to buy Tata Capital's stake in packaging co
Pharma Reviews: Self-reliant India: Which are the sectors dependent on imports, which are not
Medical devices like ventilators also rely on imports of several crucial ... India's pharmaceutical industry is capable of making finished formulations, ...
Read more: Self-reliant India: Which are the sectors dependent on imports, which are not
Read more: Self-reliant India: Which are the sectors dependent on imports, which are not
Pharma Reviews: Coronavirus Pandemic LIVE Updates: Oppn Calls Centre's Package a Big Zero, Says 'Cruel Blow ...
FICCI Welcomes PM's 'Mission Revive India' | Commenting on the set of ... set of announcements, the stage is now set to rebuild the Indian industry and ... Four domestic pharma firms — Cipla, Jubilant Life Sciences, Hetero and ...
Read more: Coronavirus Pandemic LIVE Updates: Oppn Calls Centre's Package a Big Zero, Says 'Cruel Blow ...
Read more: Coronavirus Pandemic LIVE Updates: Oppn Calls Centre's Package a Big Zero, Says 'Cruel Blow ...
Pharma Reviews: Modi's 'self-reliance' call need of the hour: Pharma industry
The Indian pharma industry on Wednesday hailed Prime Minister Narendra Modi emphasising on making India self-reliant and said his speech ...
Read more: Modi's 'self-reliance' call need of the hour: Pharma industry
Read more: Modi's 'self-reliance' call need of the hour: Pharma industry
Pharma Reviews: Pakistan lifts ban on import of Indian drugs fearing severe shortage of medicine in the country
Pharma body in Pakistan demands import from India. Pakistan's pharmaceutical industry had demanded that the ban on Indian medicines and medicinal ...
Read more: Pakistan lifts ban on import of Indian drugs fearing severe shortage of medicine in the country
Read more: Pakistan lifts ban on import of Indian drugs fearing severe shortage of medicine in the country
Pharma Reviews: Share Market Live Highlights: Sensex, Nifty end 2% higher; PSU banks best-performers, rally over ...
Share Market live News: Indian indices snapped the two-day losing streak and ... Nifty Pharma and Nifty FMCG were the only ones to end in the red.
Read more: Share Market Live Highlights: Sensex, Nifty end 2% higher; PSU banks best-performers, rally over ...
Read more: Share Market Live Highlights: Sensex, Nifty end 2% higher; PSU banks best-performers, rally over ...
Pharma Reviews: Share market update: Pharma shares slip; Aurobindo Pharma dips 3%
Shares of Torrent Pharmaceuticals (down 3.26 per cent), Aurobindo Pharma (down 2.72 per cent), Sun Pharmaceutical Industries (down 2.34 per ...
Read more: Share market update: Pharma shares slip; Aurobindo Pharma dips 3%
Read more: Share market update: Pharma shares slip; Aurobindo Pharma dips 3%
Pharma Reviews: Remdesivir to be made in India as 3 firms get nod from US drug-maker for generic version
The US firm has also allowed one drug-maker based in Pakistan, ... The agreements permit the Indian companies to sell the drug in nearly all ...
Read more: Remdesivir to be made in India as 3 firms get nod from US drug-maker for generic version
Read more: Remdesivir to be made in India as 3 firms get nod from US drug-maker for generic version
Pharma Reviews: 3 Indian firms sign licensing deal with Gilead for supply of Covid-19 drug
NEW DELHI: Indian pharmaceutical companies -- Jubliant Life Sciences Ltd, Cipla Ltd and Hetero Labs Ltd -- have signed a non-exclusive licensing ...
Read more: 3 Indian firms sign licensing deal with Gilead for supply of Covid-19 drug
Read more: 3 Indian firms sign licensing deal with Gilead for supply of Covid-19 drug
Pharma Reviews: Pakistan Lifts Ban On Import Of Lifesaving Drugs From India Over Fears Of Potentially Severe ...
A pharmaceutical body also warned that any attempt to disrupt the global supply chains related to the country's pharma industry will hamper the country's ...
Read more: Pakistan Lifts Ban On Import Of Lifesaving Drugs From India Over Fears Of Potentially Severe ...
Read more: Pakistan Lifts Ban On Import Of Lifesaving Drugs From India Over Fears Of Potentially Severe ...
Tuesday, May 12, 2020
Pharma Reviews: Stimulus to help India be among Top 5 medical devices manufacturing hubs
Likely announcements under the stimulus package are price preference for domestic manufacturers, a new medical devices law for manufacturing and ...
Read more: Stimulus to help India be among Top 5 medical devices manufacturing hubs
Read more: Stimulus to help India be among Top 5 medical devices manufacturing hubs
Pharma Reviews: Ahead of Market: 12 things that will decide stock action on Wednesday
India's industrial production witnessed a record low of -16.7 per cent in ... Orient Bell, Ajanta Pharma, Cantabil Retail Industries, Hercules Hoists and ...
Read more: Ahead of Market: 12 things that will decide stock action on Wednesday
Read more: Ahead of Market: 12 things that will decide stock action on Wednesday
Pharma Reviews: Indian fragrances, flavours industry fears losing ground to China on exports
The industry, which is an ancillary industry to FMCG, food processing and pharma industries, said in a statement that it is currently suffering heavily ...
Read more: Indian fragrances, flavours industry fears losing ground to China on exports
Read more: Indian fragrances, flavours industry fears losing ground to China on exports
Pharma Reviews: PE firms chase Indian API makers amid covid-19 disruptions
This as the government looks to push local manufacturing of pharmaceutical ingredients, making India an alternative supplier to global drug makers hit ...
Read more: PE firms chase Indian API makers amid covid-19 disruptions
Read more: PE firms chase Indian API makers amid covid-19 disruptions
Pharma Reviews: Pakistani opposition, pharma companies clash over imports from India
While Pakistan's opposition parties have questioned the permission given to import medicines and raw materials from India, pharmaceutical ...
Read more: Pakistani opposition, pharma companies clash over imports from India
Read more: Pakistani opposition, pharma companies clash over imports from India
Pharma Reviews: Teji Mandi: Post COVID-19 pandemic, economic revival to be the toughest challenge for PM Modi
The market keeps making random moves as the nation gears up for the ... Glenmark pharma has become the first Indian pharma company in India to ...
Read more: Teji Mandi: Post COVID-19 pandemic, economic revival to be the toughest challenge for PM Modi
Read more: Teji Mandi: Post COVID-19 pandemic, economic revival to be the toughest challenge for PM Modi
Pharma Reviews: India's Public Expenditure On Health Is Mere 1.28%, Compared To Global Average Of 6.3%: David ...
In the pharmaceutical sector as well, the GoI has announced measures to boost domestic production of bulk drugs and drug intermediaries, which would ...
Read more: India's Public Expenditure On Health Is Mere 1.28%, Compared To Global Average Of 6.3%: David ...
Read more: India's Public Expenditure On Health Is Mere 1.28%, Compared To Global Average Of 6.3%: David ...
Pharma Reviews: Price drives Indian pharmaceutical market growth to five-year high in FY20
For the first time in at least five years, price is the key factor driving the Rs 1.4-trillion Indian pharmaceutical market (IPM). During FY20, price ...
Read more: Price drives Indian pharmaceutical market growth to five-year high in FY20
Read more: Price drives Indian pharmaceutical market growth to five-year high in FY20
Pharma Reviews: Bajaj Finance, Nestle, Sun Pharma among 9 stocks that analysts say can offer good returns over 3 ...
Nestle IndiaNSE 2.49 % | BUY | Target Price: Rs 18,950. Currently, the ... The pharma sector has been outperforming for the last couple of months.
Read more: Bajaj Finance, Nestle, Sun Pharma among 9 stocks that analysts say can offer good returns over 3 ...
Read more: Bajaj Finance, Nestle, Sun Pharma among 9 stocks that analysts say can offer good returns over 3 ...
US FDA News: Coronavirus (COVID-19) Update: Daily Roundup May 12, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 12, 2020
Read more: Coronavirus (COVID-19) Update: Daily Roundup May 12, 2020
US FDA News: Applied Medical Recalls Python Embolectomy, BARD Embolectomy, and OTW Latis Cleaning Catheters Due to Risk of Separation During Use
The identified catheters are latex balloon catheters used for temporary blockage, closing of a blood vessel, or infusion of fluids. These catheters are at risk of tip detachment which could lead to pieces of the catheter breaking off. This could cause serious consequences.
Read more: Applied Medical Recalls Python Embolectomy, BARD Embolectomy, and OTW Latis Cleaning Catheters Due to Risk of Separation During Use
Read more: Applied Medical Recalls Python Embolectomy, BARD Embolectomy, and OTW Latis Cleaning Catheters Due to Risk of Separation During Use
Pharma Reviews: Create jobs closer to home, no migrant worker goes to the city out of his own will: Nitin Gadkari
Gadkari stated Indian industries will have to find areas that have a lot of ... Glenmark pharma has become the first Indian pharma company in India to ...
Read more: Create jobs closer to home, no migrant worker goes to the city out of his own will: Nitin Gadkari
Read more: Create jobs closer to home, no migrant worker goes to the city out of his own will: Nitin Gadkari
Pharma Reviews: Market Update: Sensex slips 190 points amid weak cues from Asian markets
Market Update: Sensex slips 190 points amid weak cues from Asian ... Glenmark pharma has become the first Indian pharma company in India to start ...
Read more: Market Update: Sensex slips 190 points amid weak cues from Asian markets
Read more: Market Update: Sensex slips 190 points amid weak cues from Asian markets
Pharma Reviews: Indian Fragrances and Flavours Industry Fears Losing its Ground to China
Considered as an ancillary industry to FMCG and Food Processing and Pharma industries, the Indian fragrances and flavours industry is well ...
Read more: Indian Fragrances and Flavours Industry Fears Losing its Ground to China
Read more: Indian Fragrances and Flavours Industry Fears Losing its Ground to China
Pharma Reviews: India in a Bear Market! We continue to focus on LQV companies for investments: Unmesh Kulkarni
... US FDA seemingly becoming a bit relaxed in granting approvals to Indian pharma companies and (c) from equity market perspective, the sector had ...
Read more: India in a Bear Market! We continue to focus on LQV companies for investments: Unmesh Kulkarni
Read more: India in a Bear Market! We continue to focus on LQV companies for investments: Unmesh Kulkarni
Pharma Reviews: COVID-19: How emerging technologies will transform manufacturing in pharma companies
Noted experts Dilip Sawhney, MD, Rockwell Automation India; SG Belapure, senior technical advisor, Indian Pharmaceutical Alliance; Arup Ghosh, ...
Read more: COVID-19: How emerging technologies will transform manufacturing in pharma companies
Read more: COVID-19: How emerging technologies will transform manufacturing in pharma companies
Pharma Reviews: Glenmark starts clinical trials for potential Covid-19 drug in India
Mumbai-based Glenmark said in a BSE filing the approval made it the first pharmaceutical company in India to be given the nod by the Drug Controller ...
Read more: Glenmark starts clinical trials for potential Covid-19 drug in India
Read more: Glenmark starts clinical trials for potential Covid-19 drug in India
Pharma Reviews: 'Textile industry should not seek financial packages', says Smriti Irani
Piramal Enterprises Limited (PEL) is one of India's leading diversified companies, with a presence in Financial Services and Pharmaceuticals.
Read more: 'Textile industry should not seek financial packages', says Smriti Irani
Read more: 'Textile industry should not seek financial packages', says Smriti Irani
Monday, May 11, 2020
US FDA News: Coronavirus (COVID-19) Update: FDA Takes New Actions to Accelerate Development of Novel Prevention, Treatment Options for COVID-19
FDA is taking important actions to help accelerate the development of prevention and treatment options for COVID-19 by providing new guidance with recommendations for innovators and researchers conducting work in this area.
Read more: Coronavirus (COVID-19) Update: FDA Takes New Actions to Accelerate Development of Novel Prevention, Treatment Options for COVID-19
Read more: Coronavirus (COVID-19) Update: FDA Takes New Actions to Accelerate Development of Novel Prevention, Treatment Options for COVID-19
Subscribe to:
Comments (Atom)